A carregar...
Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran
BACKGROUND: A new group of oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban) with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent years. Patients being treated with oral anticoagulants are at higher risk for bl...
Na minha lista:
| Publicado no: | J Clin Exp Dent |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medicina Oral S.L.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5303333/ https://ncbi.nlm.nih.gov/pubmed/28210451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4317/jced.53219 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|